As Funding Support For Research Wanes, Scientists Must Answer A Call To Arms

Apart from fashionable new arrivals such as recombinant DNA work and high-temperature superconductivity, much of science throughout the world is feeling the cold winds of freezing funds and lack of public sympathy. In terms of government finance, the halcyon days of “anything goes” for science and its practitioners are over. Science now has the task of hying to survive in a climate that has ceased to be friendly. Moreover, whichever of the traditional disciplines we consider, it i

Written byBeverly Halstead
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Apart from fashionable new arrivals such as recombinant DNA work and high-temperature superconductivity, much of science throughout the world is feeling the cold winds of freezing funds and lack of public sympathy. In terms of government finance, the halcyon days of “anything goes” for science and its practitioners are over. Science now has the task of hying to survive in a climate that has ceased to be friendly. Moreover, whichever of the traditional disciplines we consider, it is patently obvious that resources have been spread too far and too thin. In circumstances of this sort, scientists everywhere must worry about being vulnerable to extinction as a result of the feckless whims of fashion.

The earth sciences in Britain are a prime example of theproblem and, I believe, of the right solution too. Two years ago, a committee under the chairmanship of Professor Ron Oxburgh, head of the department of earth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies